Cholesterol Test Market Report 2026 Market Outlook Supported By A Forecast 9% CAGR

The cholesterol test market is gaining considerable momentum as healthcare moves toward more personalized and accessible diagnostics. Driven by technological advances and a growing emphasis on preventive care, this market is set to expand significantly in the coming years. Let's delve into the current market valuation, key players, emerging trends, and important segments shaping this industry.

Projected Growth and Market Size of the Cholesterol Test Industry
The cholesterol test market is forecasted to experience robust expansion, reaching a valuation of $15.25 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 9.0% over the forecast period. Factors propelling this increase include a rising preference for self-monitoring diagnostic technologies, greater focus on early detection of diseases, broader implementation of remote patient testing solutions, enhanced integration with digital health platforms, and the growing uptake of personalized healthcare diagnostics. Key trends expected to drive market evolution encompass wider adoption of home-based cholesterol testing kits, increased demand for point-of-care lipid testing devices, the utilization of multi-parameter lipid panels, expansion of cardiovascular preventive screening initiatives, and a heightened focus on delivering rapid and accurate test outcomes.

The cholesterol test market size has grown strongly in recent years. It will grow from $9.94 billion in 2025 to $10.8 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising awareness of cholesterol monitoring, expansion of diagnostic laboratory networks, growth in preventive healthcare screening, availability of affordable test kits.

Download a free sample of the cholesterol test market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11968&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Influencing the Cholesterol Test Market Landscape
The cholesterol test market includes several dominant players such as F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, and Diazyme Laboratories Inc.

Notably, in January 2023, SD Biosensor, Inc., a South Korean diagnostics reagent company, together with SJL Partners, a Korean private equity firm, acquired Meridian Bioscience, Inc. for $1.53 billion. This acquisition aims to enhance Meridian Bioscience's capacity to meet increasing diagnostic testing demands and foster new product developments by leveraging SDB's industry expertise and complementary strengths. Meridian Bioscience, based in the United States, focuses on manufacturing and marketing innovative diagnostic devices related to cholesterol and cardiac health.

View the full cholesterol test market report:
https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Trends Impacting the Cholesterol Test Industry Today
Market participants are heavily investing in innovative diagnostic solutions designed to improve early identification and ongoing monitoring of cholesterol levels. These advancements help tailor treatment plans, improve patient outcomes, and support preventive healthcare strategies. One such example is the development of comprehensive blood testing systems, which analyze multiple biomarkers from a single sample.

For instance, in March 2024, Babson Diagnostics, Inc., an Australian healthcare technology startup, introduced the BetterWay system. This cutting-edge blood testing platform includes the MiniDraw device, which collects fingertip blood samples by warming the patient's hand and obtaining a small, pea-sized specimen using a lancet-based tool. The system automates sample preparation with temperature control and mixing before shipping the blood to Babson's laboratory for analysis. The BetterWay system can assess cholesterol levels, blood cell counts, and liver, kidney, and thyroid functions, delivering results within one to two days while enhancing patient comfort and convenience. This innovation bridges the gap between traditional laboratory testing and point-of-care accessibility, improving routine cholesterol monitoring.

Understanding the Cholesterol Test Market Segmentation
The cholesterol test market has been segmented to provide a clear overview of its various components:

1) By Product Type:
- Test Kits
- Test Strips
- Other Product Types

2) By Test Type:
- Total Cholesterol Test
- High-Density Lipoprotein (HDL) Cholesterol
- Low-Density Lipoprotein (LDL) Cholesterol
- Triglycerides or Very Low-Density Lipoprotein (VLDL) Cholesterol Test

3) By Distribution Channel:
- Over The Counter
- Prescription Based

4) By End User:
- Hospitals
- Diagnostic Centers
- Other End Users

Further subcategories include:

- Test Kits divided into Home Testing Kits and Laboratory Testing Kits
- Test Strips categorized as Disposable Test Strips and Multi-Use Test Strips
- Other Product Types such as Point-Of-Care Testing Devices, Cholesterol Monitors, and Reagents and Calibration Solutions

This segmentation provides a detailed framework for understanding the market's structure and the diverse range of products and services available within the cholesterol testing industry.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.